President Mohamed Muizzu has amended the country’s Drug Act to allow the use of Methylphenidate, a medication commonly prescribed for Attention Deficit Hyperactivity Disorder (ADHD), making it legally available in the Maldives starting today.
The change comes after growing concerns were raised over the lack of access to the medication, particularly for children diagnosed with ADHD. The issue was formally brought to the government’s attention by Mohamed Ibrahim, who wrote to the President requesting action on the matter.
According to the President’s Office, the Cabinet reviewed recommendations provided by the National Drug Control Council before deciding last month to remove Methylphenidate from the country’s list of prohibited substances.
As required under existing law, the proposed amendment was submitted to Parliament for approval. The change was later endorsed by the relevant parliamentary committee before being passed unanimously during yesterday’s sitting, with all 51 members present voting in favour.
Following parliamentary approval, President Muizzu formalized the amendment through a presidential decree, which has now been published in the Government Gazette.
Officials said the legal amendment establishes the framework necessary for the medication to be made available in the Maldives for individuals requiring treatment for ADHD.
The decision is expected to bring relief to many families and healthcare professionals who had previously raised concerns over difficulties in accessing internationally recognized treatment options for the condition.
